Sandra Meta SwainMD, FACP, FASCO
Sandra M. Swain, MD, FACP, is a professor of medicine at Georgetown University and an adjunct professor of medicine at F. Edward Hebert School of Medicine. She was previously the deputy branch chief of the Medicine Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), and was a tenured principal investigator. Dr. Swain was also the chief of the Breast Cancer Section and chief of the Cancer Therapeutics Branch.
Dr. Swain's current research interests include translational research to identify novel and targeted therapeutics for metastatic and inflammatory breast cancer. She has a strong interest in the development of adjuvant therapy for breast cancer and the effect of chemotherapy on ovarian function. She is the chair of three international phases III randomized studies focused on the adjuvant treatment of breast cancer. She was instrumental in the approval of dexrazoxane for Cardioprotection with anthracyclines for breast cancer treatment.